Getting Started With Computational Drug Discovery

Author:

Kumari Rashmi1,Das Subhranil2,Singh Raghwendra Kishore3,Kohli Anvi4,Sunil Arya4,Dadhich Arushi4

Affiliation:

1. Bennett University, India

2. MIT World Peace University, India

3. Department of Electronics and Communication Engineering, Bharat Institute of Engineering and Technology, Hyderabad, India

4. School of Computer Science Engineering and Technology, Bennett University, India

Abstract

This manuscript explores the transformative impact of computational drug discovery in pharmaceutical research, emphasizing the integration of algorithms, simulations, and modeling to expedite the development of therapeutic agents. It highlights the multidisciplinary nature of this approach, leveraging insights from computer science, chemistry, biology, and pharmacology. The narrative underscores the crucial role of artificial intelligence (AI) and machine learning (ML) technologies in enhancing the efficiency and precision of drug discovery. These technologies enable the analysis of complex biological data, facilitating the identification of novel drug targets and the prediction of drug efficacies and side effects with unprecedented accuracy. Additionally, the chapter discusses the significance of computational methodologies in improving the speed, cost-effectiveness, and success rates of developing new drugs. Through high-throughput screening and detailed molecular analysis, these methods allow for the rapid identification of promising compounds and offer insights into disease mechanisms, paving the way for targeted therapeutic interventions. This overview aims to showcase the critical role of computational drug discovery in advancing personalized, effective, and patient-centered treatments, marking a significant shift towards more innovative and efficient drug development processes.

Publisher

IGI Global

Reference49 articles.

1. Quantitative structure-activity relationship (QSAR) modelling study of some novel carboxamide series as new anti-tubercular agents

2. High-Throughput Screening: today’s biochemical and cell-based approaches

3. Bovdilova, A. (2020). Molecular adaptations and post-translational regulation of C4-NADP-malic enzyme [Doctoral dissertation, Dissertation, Düsseldorf, Heinrich-Heine-Universität, 2019].

4. CaseD. A.AktulgaH. M.BelfonK.Ben-ShalomI.BrozellS. R.CeruttiD. S.KollmanP. A. (2021). Amber 2021. University of California.

5. Cheng, T., Li, Q., Zhou, Z., Wang, Y., & Bryant, S. H. (2012). Structure-based virtual screening for drug discovery: a problem-centric review. The AAPS Journal, 14(1), 133-141.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3